Men who became ill in drug trial improve

doi:10.1136/bmj.332.7545.812-a

BMJ 2006;332:812 (8 April), doi:10.1136/bmj.332.7545.812-a

News roundup

Men who became ill in drug trial improve

London Susan Mayor

Four of the six men who became seriously ill in a UK clinical trial of a monoclonal antibody, TGN1412 (BMJ 2006;332:683, 25 Mar), have been allowed to return home, the hospital that cared for them said this week.

In a statement Ganesh Suntharalingam, clinical director of intensive care at Northwick Park Hospital, London, said: “There has been continued progress amongst the patients since they were transferred here on 13 March following a drug trial.” He said that four of the men had improved enough to be allowed home. A fifth patient was no longer in critical care and was making a steady recovery, under close observation.

“A sixth patient remains in critical care, but he is now fully conscious, and we are encouraged by his progress,” said Dr Suntharalingam, before the BMJ went to press on Tuesday.

One of the six men, Mohamed Abdelhady, aged 28, . . . [Full text of this article]

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?